| Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis RS Taylor, S Walker, NA Smart, MF Piepoli, FC Warren, O Ciani, ... Journal of the American College of Cardiology 73 (12), 1430-1443, 2019 | 233 | 2019 |
| Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study O Ciani, M Buyse, R Garside, T Pavey, K Stein, JAC Sterne, RS Taylor Bmj 346, 2013 | 172 | 2013 |
| Impact of exercise‐based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta‐analysis of … RS Taylor, S Walker, NA Smart, MF Piepoli, FC Warren, O Ciani, ... European journal of heart failure 20 (12), 1735-1743, 2018 | 169 | 2018 |
| Determinants of demand for total hip and knee arthroplasty: a systematic literature review REM Mota, R Tarricone, O Ciani, JFP Bridges, M Drummond BMC health services research 12, 1-18, 2012 | 144 | 2012 |
| Time to review the role of surrogate end points in health policy: state of the art and the way forward O Ciani, M Buyse, M Drummond, G Rasi, ED Saad, RS Taylor Value in Health 20 (3), 487-495, 2017 | 128 | 2017 |
| An economic perspective on urinary tract infection: the “costs of resignation” O Ciani, D Grassi, R Tarricone Clinical drug investigation 33, 255-261, 2013 | 97 | 2013 |
| Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers O Ciani, S Davis, P Tappenden, R Garside, K Stein, A Cantrell, ED Saad, ... International journal of technology assessment in health care 30 (3), 312-324, 2014 | 88 | 2014 |
| De innovatione: The concept of innovation for medical technologies and its implications for healthcare policy-making O Ciani, P Armeni, PR Boscolo, M Cavazza, C Jommi, R Tarricone Health Policy and Technology 5 (1), 47-64, 2016 | 84 | 2016 |
| A randomized, open‐label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder … M Cervigni, M Sommariva, R Tenaglia, D Porru, E Ostardo, A Giammò, ... Neurourology and Urodynamics 36 (4), 1178-1186, 2017 | 79 | 2017 |
| Response to COVID-19: was Italy (un) prepared? I Bosa, A Castelli, M Castelli, O Ciani, A Compagni, MM Galizzi, ... Health Economics, Policy and Law 17 (1), 1-13, 2022 | 76 | 2022 |
| Health technology assessment of medical devices: a survey of non-European union agencies O Ciani, B Wilcher, CR Blankart, M Hatz, VP Rupel, RS Erker, ... International journal of technology assessment in health care 31 (3), 154-165, 2015 | 74 | 2015 |
| Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis. RS Taylor, S Walker, O Ciani, F Warren, NA Smart, M Piepoli, CH Davos Health Technology Assessment (Winchester, England) 23 (25), 1, 2019 | 73 | 2019 |
| Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre … O Ciani, E Arendsen, M Romancik, R Lunik, E Costantini, M Di Biase, ... BMJ open 6 (3), e009669, 2016 | 73 | 2016 |
| Validation of exercise capacity as a surrogate endpoint in exercise-based rehabilitation for heart failure: a meta-analysis of randomized controlled trials O Ciani, M Piepoli, N Smart, J Uddin, S Walker, FC Warren, AD Zwisler, ... JACC: Heart Failure 6 (7), 596-604, 2018 | 72 | 2018 |
| Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses C Rognoni, O Ciani, S Sommariva, A Facciorusso, R Tarricone, S Bhoori, ... Oncotarget 7 (44), 72343, 2016 | 69 | 2016 |
| Harnessing digital health technologies during and after the COVID-19 pandemic: context matters F Petracca, O Ciani, M Cucciniello, R Tarricone Journal of medical Internet research 22 (12), e21815, 2020 | 68 | 2020 |
| The role of health technology assessment bodies in shaping drug development O Ciani, C Jommi Drug design, development and therapy, 2273-2281, 2014 | 63 | 2014 |
| Linking the regulatory and reimbursement processes for medical devices: the need for integrated assessments O Ciani, B Wilcher, A van Giessen, RS Taylor Health Economics 26, 13-29, 2017 | 61 | 2017 |
| Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems? O Ciani, R Tarricone, A Torbica Health Policy 108 (2-3), 194-202, 2012 | 57 | 2012 |
| Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer O Ciani, M Buyse, R Garside, J Peters, ED Saad, K Stein, RS Taylor Journal of clinical epidemiology 68 (7), 833-842, 2015 | 55 | 2015 |
Rosanna TarriconeBocconi UniversityEmail verificata su unibocconi.it
